SEC Form 3 · accession 0001493152-18-009680
Provention Bio, Inc. · PRVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
MDB CAPITAL GROUP LLC
10% Owner
Period of report
Jul 3, 2018
Accepted (ET)
Jul 3, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001695357
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,371,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant To Purchase Series A Preferred Stock (right to buy)F1 | $2.50 | holding | — | — | — | Apr 25, 2017 | Apr 25, 2024 | Series A Preferred Stock | 274,289 | — | D |
Explanation of responses
- F1Represents shares of Series A Preferred Stock that will automatically convert to the same number of shares of Common Stock immediately after the closing of the Issuer' Initial Public Offering.